Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Weickhardt AJ"'
Autor:
Weickhardt, Aj, Doebele, Rc, Purcell, Wt, Bunn, Pa, Oton, Ab, Rothman, Ms, Wierman, Me, Mok, T, Popat, S, Bauman, J, Nieva, J, Novello, Silvia, Ou, Sh, Camidge, D. R.
Crizotinib is a tyrosine kinase inhibitor active against ALK, MET, and ROS1. We previously reported that crizotinib decreases testosterone in male patients. The detailed etiology of the effect, its symptomatic significance, and the effectiveness of s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7557112dac6247f1440922d4c5d41ae3
https://europepmc.org/articles/PMC3686910/
https://europepmc.org/articles/PMC3686910/
Autor:
Weickhardt AJ, Scheier B, Burke JM, Gan G, Lu X, Bunn PA Jr, Aisner DL, Gaspar LE, Kavanagh BD, Doebele RC, Camidge DR, Weickhardt, Andrew J, Scheier, Benjamin, Burke, Joseph Malachy, Gan, Gregory, Lu, Xian, Bunn, Paul A Jr, Aisner, Dara L, Gaspar, Laurie E, Kavanagh, Brian D
Publikováno v:
Journal of Thoracic Oncology; 2012 Dec, Vol. 7 Issue 12, p1807-1814, 8p
Autor:
Weickhardt AJ; Olivia Newton-John Cancer and Research Institute, Melbourne, VIC, Australia. Andrew.weickhardt@austin.org.au.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia. Andrew.weickhardt@austin.org.au.; Department of Medical Oncology, Austin Health, Olivia Newton-John Cancer Wellness and Research Centre, Melbourne, VIC, Australia. Andrew.weickhardt@austin.org.au., Lau DK; Olivia Newton-John Cancer and Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Hodgson-Garms M; Olivia Newton-John Cancer and Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Lavis A; Olivia Newton-John Cancer and Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Jenkins LJ; Olivia Newton-John Cancer and Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Vukelic N; Olivia Newton-John Cancer and Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Ioannidis P; Olivia Newton-John Cancer and Research Institute, Melbourne, VIC, Australia., Luk IY; Olivia Newton-John Cancer and Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Mariadason JM; Olivia Newton-John Cancer and Research Institute, Melbourne, VIC, Australia. john.mariadason@onjcri.org.au.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia. john.mariadason@onjcri.org.au.; Department of Medical Oncology, Austin Health, Olivia Newton-John Cancer Wellness and Research Centre, Melbourne, VIC, Australia. john.mariadason@onjcri.org.au.; Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia. john.mariadason@onjcri.org.au.
Publikováno v:
BMC cancer [BMC Cancer] 2022 May 02; Vol. 22 (1), pp. 478. Date of Electronic Publication: 2022 May 02.
Autor:
Chionh F; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia., Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, 2006, Australia., Al-Obaidi SJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia., Mooi JK; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia., Bruhn MA; Haematology-Oncology Department, Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville, SA, 5001, Australia., Lee CK; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, 2006, Australia., Chüeh AC; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VIC, 3084, Australia.; Cancer Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, 3168, Australia., Williams DS; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, 3086, Australia.; Department of Pathology, Austin Health, Heidelberg, VIC, 3084, Australia.; Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, 3010, Australia., Weickhardt AJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia., Wilson K; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, 2006, Australia., Scott AM; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, 3086, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, VIC, 3084, Australia., Simes J; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, 2006, Australia., Hardingham JE; Haematology-Oncology Department, Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville, SA, 5001, Australia.; School of Medicine, University of Adelaide, Adelaide, SA, 5005, Australia., Price TJ; Haematology-Oncology Department, Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville, SA, 5001, Australia.; School of Medicine, University of Adelaide, Adelaide, SA, 5005, Australia., Mariadason JM; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia. john.mariadason@onjcri.org.au.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, 3086, Australia. john.mariadason@onjcri.org.au., Tebbutt NC; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia. niall.tebbutt@austin.org.au.; Department of Medical Oncology, Austin Health, Heidelberg, VIC, 3084, Australia. niall.tebbutt@austin.org.au.; Department of Surgery, The University of Melbourne, Parkville, VIC, 3010, Australia. niall.tebbutt@austin.org.au.
Publikováno v:
Scientific reports [Sci Rep] 2022 Jan 24; Vol. 12 (1), pp. 1238. Date of Electronic Publication: 2022 Jan 24.
Autor:
Lau DK; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia., Luk IY; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia., Jenkins LJ; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia., Martin A; NHMRC Clinical trials Centre, Sydney University, Sydney, New South Wales, Australia.; Cancer Care Centre, St. George Hospital, Kogarah, New South Wales, Australia., Williams DS; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia., Schoffer KL; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia., Chionh F; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia., Buchert M; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia., Sjoquist K; NHMRC Clinical trials Centre, Sydney University, Sydney, New South Wales, Australia.; Cancer Care Centre, St. George Hospital, Kogarah, New South Wales, Australia., Boussioutas A; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Medicine, University of Melbourne, Parkville, Victoria, Australia., Hayes SA; Kolling Institute for Medical Research, Royal North Shore Hospital, Sydney, New South Wales, Australia., Ernst M; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia., Weickhardt AJ; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia., Pavlakis N; Kolling Institute for Medical Research, Royal North Shore Hospital, Sydney, New South Wales, Australia., Tebbutt NC; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia. john.mariadason@onjcri.org.au niall.tebbutt@onjcri.org.au.; Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia.; Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia., Mariadason JM; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia. john.mariadason@onjcri.org.au niall.tebbutt@onjcri.org.au.; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.; Cancer Care Centre, St. George Hospital, Kogarah, New South Wales, Australia.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Apr; Vol. 20 (4), pp. 704-715. Date of Electronic Publication: 2021 Feb 09.
Autor:
Scott AM; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia.; Department of Molecular Imaging and Therapy, Austin Hospital, and University of Melbourne, Heidelberg, Victoria 3084, Australia.; Ludwig Institute for Cancer Research, Melbourne Branch, Heidelberg, Victoria 3084, Australia., Akhurst T; Centre for Cancer Imaging, the Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; The Sir Peter MacCallum Department of Oncology, the University of Melbourne Melbourne, Victoria 3000, Australia., Lee FT; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia., Ciprotti M; Ludwig Institute for Cancer Research, Melbourne Branch, Heidelberg, Victoria 3084, Australia., Davis ID; Ludwig Institute for Cancer Research, Melbourne Branch, Heidelberg, Victoria 3084, Australia.; Eastern Health, Melbourne, Australia.; Monash University, Melbourne, Australia., Weickhardt AJ; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia.; Department of Medical Oncology, Austin Health, Heidelberg, Victoria 3084, Australia., Gan HK; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia.; Department of Medical Oncology, Austin Health, Heidelberg, Victoria 3084, Australia., Hicks RJ; Centre for Cancer Imaging, the Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Lee ST; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia.; Department of Molecular Imaging and Therapy, Austin Hospital, and University of Melbourne, Heidelberg, Victoria 3084, Australia., Kocovski P; Ludwig Institute for Cancer Research, Melbourne Branch, Heidelberg, Victoria 3084, Australia., Guo N; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia., Oh M; Avipep Pty Ltd and the Victorian Cancer Biologics Consortium, Parkville, Victoria 3052, Australia., Mileshkin L; The Sir Peter MacCallum Department of Oncology, the University of Melbourne Melbourne, Victoria 3000, Australia., Williams S; The Sir Peter MacCallum Department of Oncology, the University of Melbourne Melbourne, Victoria 3000, Australia., Murphy D; The Sir Peter MacCallum Department of Oncology, the University of Melbourne Melbourne, Victoria 3000, Australia., Pathmaraj K; Department of Molecular Imaging and Therapy, Austin Hospital, and University of Melbourne, Heidelberg, Victoria 3084, Australia., O'Keefe GJ; Department of Molecular Imaging and Therapy, Austin Hospital, and University of Melbourne, Heidelberg, Victoria 3084, Australia., Gong SJ; Department of Molecular Imaging and Therapy, Austin Hospital, and University of Melbourne, Heidelberg, Victoria 3084, Australia., Pedersen JS; TissuPath Specialist Pathology, Mount Waverley, Victoria 3149, Australia., Scott FE; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia., Wheatcroft MP; Avipep Pty Ltd and the Victorian Cancer Biologics Consortium, Parkville, Victoria 3052, Australia., Hudson PJ; Avipep Pty Ltd and the Victorian Cancer Biologics Consortium, Parkville, Victoria 3052, Australia.
Publikováno v:
Theranostics [Theranostics] 2020 Sep 15; Vol. 10 (25), pp. 11404-11415. Date of Electronic Publication: 2020 Sep 15 (Print Publication: 2020).
Autor:
Lau DK; Olivia Newton John Cancer Research Institute, Austin Health, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, Melbourne, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia., Mouradov D; Systems Biology and Personalised Medicine Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC 3052, Australia., Wasenang W; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia; Centre for Research and Development of Medical Diagnostic Laboratories, Khon Kaen University, Khon Kaen 40002, Thailand., Luk IY; Olivia Newton John Cancer Research Institute, Austin Health, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, Melbourne, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia., Scott CM; Olivia Newton John Cancer Research Institute, Austin Health, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, Melbourne, VIC 3084, Australia., Williams DS; Olivia Newton John Cancer Research Institute, Austin Health, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, Melbourne, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia., Yeung YH; Olivia Newton John Cancer Research Institute, Austin Health, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, Melbourne, VIC 3084, Australia., Limpaiboon T; Centre for Research and Development of Medical Diagnostic Laboratories, Khon Kaen University, Khon Kaen 40002, Thailand., Iatropoulos GF; Olivia Newton John Cancer Research Institute, Austin Health, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, Melbourne, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia., Jenkins LJ; Olivia Newton John Cancer Research Institute, Austin Health, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, Melbourne, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia., Reehorst CM; Olivia Newton John Cancer Research Institute, Austin Health, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, Melbourne, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia., Chionh F; Olivia Newton John Cancer Research Institute, Austin Health, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, Melbourne, VIC 3084, Australia., Nikfarjam M; Department of Surgery, University of Melbourne, Melbourne, VIC 3084, Australia., Croagh D; Department of Surgery, Monash Medical Centre, Monash University, Melbourne, VIC 3168, Australia., Dhillon AS; Olivia Newton John Cancer Research Institute, Austin Health, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, Melbourne, VIC 3084, Australia; School of Medicine, Deakin University, Geelong, VIC 3216, Australia., Weickhardt AJ; Olivia Newton John Cancer Research Institute, Austin Health, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, Melbourne, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia., Muramatsu T; Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, Tokyo 105-8512, Japan., Saito Y; Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, Tokyo 105-8512, Japan., Tebbutt NC; Olivia Newton John Cancer Research Institute, Austin Health, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, Melbourne, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia., Sieber OM; Systems Biology and Personalised Medicine Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC 3052, Australia; Department of Surgery, University of Melbourne, Melbourne, VIC 3084, Australia; Department of Biochemistry & Molecular Biology, Monash University, Melbourne, VIC 3800, Australia; Department of Medicine, The University of Melbourne, Melbourne, VIC 3052, Australia., Mariadason JM; Olivia Newton John Cancer Research Institute, Austin Health, Level 5 ONJ Centre, 145 Studley Road, Heidelberg, Melbourne, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia; Department of Medicine, The University of Melbourne, Melbourne, VIC 3052, Australia. Electronic address: john.mariadason@onjcri.org.au.
Publikováno v:
IScience [iScience] 2019 Nov 22; Vol. 21, pp. 624-637. Date of Electronic Publication: 2019 Oct 31.
Autor:
Ha FJ; Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital, Melbourne, Victoria, Australia., Spain L; Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital, Melbourne, Victoria, Australia., Dowling A; Department of Medical Oncology, St Vincent's Hospital, Melbourne, Victoria, Australia., Kwan EM; Department of Medical Oncology, Monash Health, Melbourne, Victoria, Australia., Pezaro C; Eastern Health and Monash University, Melbourne, Victoria, Australia., Day D; Department of Medical Oncology, The Royal Melbourne Hospital, Parkville, Victoria, Australia., Chia PL; Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital, Melbourne, Victoria, Australia., Tran B; Department of Medical Oncology, The Royal Melbourne Hospital, Parkville, Victoria, Australia., Pook D; Department of Medical Oncology, Monash Health, Melbourne, Victoria, Australia., Weickhardt AJ; Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital, Melbourne, Victoria, Australia.
Publikováno v:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2019 Oct; Vol. 15 (5), pp. e97-e102. Date of Electronic Publication: 2019 Jan 30.
Autor:
Kramer GM; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands ge.kramer@vumc.nl., Yaqub M; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Vargas HA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Schuit RC; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Windhorst AD; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van der Veldt AAM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Departments of Medical Oncology, Radiology, and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands., Bergman AM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Burnazi EM; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Lewis JS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Weill Cornell Medicine, New York, New York., Chua S; Department of Nuclear Medicine, Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Staton KD; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Beattie BJ; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Humm JL; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Davis ID; Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia., Weickhardt AJ; Department of Medical Oncology, Olivia Newton-John Cancer Research Institute, Austin Hospital, Melbourne, Victoria, Australia., Scott AM; Department of Medical Oncology, Olivia Newton-John Cancer Research Institute, Austin Hospital, Melbourne, Victoria, Australia.; Department of Molecular Imaging and Therapy, University of Melbourne, Heidelberg, Victoria, Australia., Morris MJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; and.; Department of Medicine, Weill Cornell Medicine, New York, New York., Hoekstra OS; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Lammertsma AA; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2019 Sep; Vol. 60 (9), pp. 1221-1227. Date of Electronic Publication: 2019 Mar 08.
Autor:
Hamid AA; Department of Medical Oncology, Olivia Newton-John Cancer Wellness and Research Center, Austin Hospital, Heidelberg, Victoria, Australia., Ha FJ; Department of Medical Oncology, Olivia Newton-John Cancer Wellness and Research Center, Austin Hospital, Heidelberg, Victoria, Australia., Das O; Department of Medical Oncology, Olivia Newton-John Cancer Wellness and Research Center, Austin Hospital, Heidelberg, Victoria, Australia., Weickhardt AJ; Department of Medical Oncology, Olivia Newton-John Cancer Wellness and Research Center, Austin Hospital, Heidelberg, Victoria, Australia. andrew.weickhardt@onjcri.org.au.
Publikováno v:
Annals of palliative medicine [Ann Palliat Med] 2018 Oct; Vol. 7 (4), pp. 404-410. Date of Electronic Publication: 2018 Jun 16.